Passage Bio, Inc.
PASG
$4.94
$0.091.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.87M | 4.79M | 4.92M | 4.35M | 4.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.22M | 8.88M | 10.34M | 8.66M | 10.33M |
| Operating Income | -10.22M | -8.88M | -10.34M | -8.66M | -10.33M |
| Income Before Tax | -7.82M | -7.56M | -12.98M | -7.75M | -9.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.82M | -7.56M | -12.98M | -7.75M | -9.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.82M | -7.56M | -12.98M | -7.75M | -9.39M |
| EBIT | -10.22M | -8.88M | -10.34M | -8.66M | -10.33M |
| EBITDA | -10.19M | -8.75M | -10.16M | -8.47M | -10.17M |
| EPS Basic | -2.44 | -2.36 | -4.08 | -2.44 | -2.96 |
| Normalized Basic EPS | -1.90 | -1.60 | -1.86 | -1.52 | -1.85 |
| EPS Diluted | -2.44 | -2.36 | -4.08 | -2.44 | -2.96 |
| Normalized Diluted EPS | -1.90 | -1.60 | -1.86 | -1.52 | -1.85 |
| Average Basic Shares Outstanding | 3.21M | 3.21M | 3.18M | 3.18M | 3.17M |
| Average Diluted Shares Outstanding | 3.21M | 3.21M | 3.18M | 3.18M | 3.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |